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Studies of palate development are motivated by the all too common incidence of cleft
palate, a birth defect that imposes a tremendous health burden and can leave lasting
disfigurement. Although, mechanistic studies of palate growth and fusion have focused
on growth factors such as Transforming Growth Factor ß-3 (Tgfß3), recent studies have
revealed that the ephrin family of membrane bound ligands and their receptors, the Ephs,
play central roles in palatal morphogenesis, growth, and fusion. In this mini-review, we
will discuss the recent findings by our group and others on the functions of ephrins in
palatal development.
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OVERVIEW OF PALATE DEVELOPMENT
The bony secondary palate forms the roof of the mouth and
separates the oral and nasal cavities. In mammals, it originates
as two shelves of cranial neural crest-derived mesenchyme that
grow vertically on either side of the tongue and then elevate over
the tongue to grow toward the midline. Fusion of the secondary
palate requires the midline juxtaposition of the two-cell-thick
epithelium that covers the palatal shelves. Upon contact, the outer
periderm layer on each shelf sloughs off, and the basal epithe-
lial layers from each shelf adhere to form the midline epithelial
seam (MES), which becomes stabilized by desmosomal junctions
between the adhering cells. The MES then degrades to leave a
confluent mesenchymal shelf that ultimately ossifies (Nawshad,
2008) (Figure 1A). The fate of the MES cells during fusion has
long been a source of controversy. One theory has the cells dying
by apoptosis (Glücksmann, 1965; Martínez-Alvarez et al., 2000;
Cuervo and Covarrubias, 2004), while another says they undergo
epithelial-to-mesenchymal transition (EMT) andmigrate into the
surrounding mesenchyme (Fitchett and Hay, 1989; Shuler et al.,
1991, 1992; Kang and Svoboda, 2002, 2005). Current evidence on
the mechanism of MES degradation best fits a model in which
the medial edge epithelial (MEE) cells undergo EMT, followed by
apoptosis (Ahmed et al., 2007).
For most of two decades, it has been understood that MEE
degradation and palatal fusion requires Tgfß3. In mammalian
palates, which normally fuse on their own, this factor is produced
by the palatal tissue itself (Proetzel et al., 1995; Taya et al., 1999),
and genetic ablation of Tgfß3 results in cleft palate. Chicken
palates, which do not normally fuse, can be induced to fuse by
adding exogenous Tgfß3, thus showing that they retain the sig-
naling machinery to respond to this factor and validating the
chicken as a useful model system to study palate development
(Sun et al., 1998). In addition to the apparent requirement for
diffusible Tgfß3, there is a contact-mediated signal that is also
needed to initiate fusion. Palatal shelves (chicken or mouse) will
not degrade their epithelial layers unless placed in direct contact,
even when supplied with exogenous Tgfß3 (Sun et al., 1998).
Recent studies suggest that this contact-mediated signal may be
supplied by members of the ephrin family of membrane-bound
ligands.
EPHRIN INVOLVEMENT IN PALATAL GROWTH AND FUSION
The Eph family is the largest family of mammalian receptor tyro-
sine kinases. Ephs and their membrane-bound ephrin ligands
are responsible for multiple adhesion, migration, and boundary-
forming events throughout development, particularly midline
fusion events such as urorectal closure (Kullander and Klein,
2002; Murai and Pasquale, 2003; Dravis et al., 2004). Binding of
ephrins to Ephs on opposing cells causes kinase activation in the
Eph-bearing cells (forward signaling), while binding of Ephs can
activate intracellular signaling inside ephrin-bearing cells (reverse
signaling). Ephrin-Bs are transmembrane proteins that have
conserved intracellular signaling domains while ephrin-As are
glycosylphosphatidyl-inositol (GPI)-linked and use co-receptors
to signal. Ephrin-As preferentially bind to the EphA subclass of
receptors, while ephrin-Bs bind to EphBs, although there is phys-
iologically relevant binding across classes, most notably between
EphA4 and all three B ephrins.
Over the years, a number of genetically modified Eph and
ephrin alleles have been created in mice to both track expres-
sion of these molecules and to examine the roles of forward
and reverse signaling in developmental processes. In addition
to traditional gene knockouts, several LacZ knock-in alleles
have been generated. In these, either the entire protein or just
the cytoplasmic domain of the Eph or ephrin-B in question
is replaced with a bacterial beta-galactosidase moiety that can
be visualized in tissue by incubation with X-gal to produce
a blue precipitate. The chimeric alleles are especially useful
because they lack intracellular signaling ability while retaining
activity as ligands from their extracellular domains. Thus, they
can be used to dissect forward and reverse ephrin signaling
pathways.
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FIGURE 1 | Ephs and ephrins in fusing palate. (A) Steps in mammalian
palatal fusion. Palatal shelves of mesenchyme ensheathed in a two-cell
thick epithelial layer elevate over the tongue and grow to midline. This
happens beginning at about embryonic day 12.5 in the mouse. At e14.5,
the epithelial cells adhere, migrate into the mesenchyme and/or die, leaving
a confluent mesenchymal shelf. (B) Summary of published patterns of Eph
and ephrin expression in the palate just before and during fusion.
The first evidence that ephrins play a role in palate
development came with the linkage of 26 separate ephrin-B1
mutations to craniofrontonasal syndrome in humans, of which
cleft palate is a prominent feature (Twigg et al., 2004; Wieland
et al., 2005). At the same time, Davy, et al. reported that deletion
of ephrin-B1 in cranial neural crest cells in mice caused cranio-
facial deformities, including cleft palate (Davy et al., 2004). The
fact that these defects resulted from cell-autonomous ephrin-B1
deletion suggested that ephrin-B1 reverse signaling is important
for palate formation. Five years later, Risley et al. reported that
forward signaling through the combination of EphB2 and EphB3
is necessary for growth of palatal mesenchyme (Risley et al.,
2009). These authors used EphB2 LacZ/LacZ; EphB3 -/- com-
pound mutant mice to create forward signaling double knockout
mice (EphB3 signaling is removed while EphB2 forward signal-
ing is removed and reverse signaling is still intact). These mice
had cleft palate from stunted palatal shelf growth, while EphB2
and EphB3 single mutants alone did not. Shortly after the Risley
study, Bush et al. found that forward signaling from ephrin-B1 in
palate mesenchyme was required for mesenchymal proliferation
through a mechanism requiring MAPK/ERK activation. Without
ephrin-B1, mice displayed cleft palate because the shelves failed
to grow to midline (Bush and Soriano, 2010). These data together
suggest that Ephs B2 and B3 function as the receptors for ephrin-
B1 in palate mesenchyme. The EphB2 kinase was recently shown
to increase proliferation in intestinal cypts through stimulation
of Cyclin-D1 levels downstream of Abl activation (Genander
et al., 2009). It will be interesting to see if this mechanism is
also at play involved in palatal mesenchyme and is thus part of
a more generalized program of EphB regulated proliferation in
development.
When palatal shelves from EphB2 LacZ/LacZ; EphB3 -/- com-
pound mutants were placed in contact with each other in culture,
they adhered to form an MES and fused normally (Risley et al.,
2009). This demonstrated that EphB2 and EphB3 forward signal-
ing are not required for fusion, and that reverse signaling from
EphB3 alone is not critical for fusion, although the extracellu-
lar domain of EphB2 was still able to act as a ligand for reverse
signaling in these mice.
We examined in embryonic palate the expression of Ephs and
ephrins for which we had LacZ indicator mouse lines. A sum-
mary of these expression patterns in fusing palate combined
with those for Ephs and ephrins in the published literature is
presented in Figure 1B. We found that ephrin-B2 and EphB2
were expressed specifically in the MES immediately prior to and
during its degradation. This suggested to us that ephrin signal-
ing contributes to palatal EMT and fusion. We found that by
adding EphB2/Fc chimeric protein clustered with anti-Fc (Ephs
and ephrins must be aggregated into clusters of at least four
to have biological activity as ligands), we could cause fusion in
chicken palates, even without adding the Tgfß3 that is normally
required in chicken for fusion. This confirmed that EphB2 can
indeed act as a ligand to induce fusion. Further, we observed that
addition of unclustered EphA4/Fc protein, which promiscuously
binds all B-ephrins without activating signaling and thus acts as
a competitive inhibitor, blocked fusion even in the presence of
Tgfß3. We also applied unclustered EphA4/Fc to mouse palates in
culture and effectively blocked their fusion. Together, these exper-
iments demonstrated that ephrin-B reverse signaling is necessary
and sufficient for palate fusion (San Miguel et al., 2011).
Shortly following publication of our findings, Dravis et al.
reported a study in which 26% of mice homozygous for the
ephrin-B2/LacZ allele had cleft palate (Dravis and Henkemeyer,
2011). While this supports our findings, the fact that only a
minority of these embryos had cleft palate, suggests that other
Eph and ephrin family members contribute to reverse signaling at
the midline and remain unaccounted for. This is not surprising,
as Eph/ephrin mediated developmental processes are frequently
under redundant control by multiple family members, includ-
ing in palate, as noted above. We used our ex vivo palate culture
system to examine fusion ability of palatal shelves from ephrin-
B1 and ephrin-B2 classical knockout mice and found that both
single knockouts fused. However, both showed deficiencies in
medial and posterior fusion compared to wild type littermate
controls. This suggests a delay in fusion caused by these knock-
outs (Maria J. Serrano and M. Douglas Benson unpublished
observations). Unfortunately, we were unable to generate double
knockout embryos to examine the effect of combined ephrin-
B1 and -B2 abrogation. Interestingly, the study by Dravis et al.
also showed ephrin-B2 expression in the mesenchyme before its
re-localization to the MEE at the time of fusion, suggesting that
ephrin-B2 plays a role in palatal shelf growth alongside ephrin-B1.
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They also showed EphB3 expression in the MEE at fusion, impli-
cating it in the fusion process. These data emphasize the likely
involvement of multiple Eph and ephrin family members in both
phases of palatal development.
If ephrin-B1 is expressed in the palatal mesenchyme, and
ephrin-B2 in the epithelium, how might these two molecules
combine to mediate MES degradation and fusion? One possible
answer may be found in recent studies on the role of ephrin sig-
naling in cancer cell migration. Astin et al. demonstrated that
prostate cancer cells are prodded along in their migration through
fibroblasts by the activation of EphB3/EphB4 forward signaling
in response to ephrin-B2 ligand from the surrounding fibroblasts
(Astin et al., 2010). This forward signal activates Cdc42 within
the cancer cells to eliminate contact inhibition and increase their
invasiveness. It may be that a similar mechanism is at work in
palatal MEE cell migration through the ephrin-B1-expressing
mesenchyme. Whereas reverse signaling in MEE cells initiated
by contact with Ephs (acting as ligands in reverse signaling) on
the opposing shelf MEE begins the process of EMT, mesenchy-
mal ephrin-B1 (acting as ligand) activates forward signaling in
the former epithelial cells to continue their migration and com-
plete MES degradation. Ephrin-B1 may also provide a signal to
the migrating former MEE cells that causes their eventual apop-
tosis, as B ephrin forward signaling is known to cause apoptosis
in other systems (Davies et al., 2009).
EPHRIN SIGNALING IN PALATAL EMT AND FUSION
As described above, we found that activation of ephrin reverse
signaling in the chicken palate is sufficient to cause palatal fusion
without the presence of Tgfß3, and that Tgfß3 cannot cause
fusion without the ephrin signal. Yet there is clearly a question
of signaling level. The fact that chicken palates cultured without
Tgfß3 will not fuse unless exogenous EphB2/Fc is added, and that
Tgfß3 knockout mouse palates do not normally fuse, indicates
that the level of ephrin reverse signal naturally present in palatal
tissue is not enough to overcome a lack of Tgfß signaling. The
Tgfß3 and ephrin pathways must interact in one of two ways.
The first possibility is that Tgfß3 activates expression of ephrins
and/or Ephs in palate tissue to reach a threshold level required to
activate fusion. In this model, ephrins are genetically and mecha-
nistically downstream of Tgfß3. The second is that the two act in
parallel, but intersect such that the Tgfß3-activated signals add to
those elicited by ephrin activation to reach the level necessary to
cause MES degradation. The ephrin signal must still be preemi-
nent; however, as elevated ephrin stimulation obviated the need
for Tgfß3 in our palate fusion assay, while addition of exogenous
Tgfß3 did not compensate for a lack of ephrin signal. The activ-
ity of phosphatidylinositol 3-kinase (PI3K) is required for Tgfß3
stimulation of fusion (Kang and Svoboda, 2002), and our recent
study discovered that the same is true for ephrin reverse signal-
ing (San Miguel et al., 2011), as palates stimulated in culture
with EphB2/Fc did not fuse in the presence of the PI3K inhibitor
LY294002.
Our data on ephrin-B2 expression supports the EMT model
of palatal fusion in that we observed the cells of the ephrin-
B2-positive MES in the act of dispersing into palatal mes-
enchyme during fusion. Epithelial cells have a polarized, inflexible
morphology maintained by specific networks of intermediate fil-
aments, cell-cell junctions, and adhesions to the extracellular
matrix. The transition to a more fibroblastic, motile phenotype
such as is observed in the palatal MES, requires the dismantling
of these networks in favor of a more fluid cytoskeletal arrange-
ment andmore plastic cell-cell contacts. Cytokeratin intermediate
filaments disappear in favor of vimentin, laminin-1 content in
the extracellular matrix decreases as fibronectin increases, and
E-cadherin based adherins junctions are replaced by N-cadherin
based cell-cell contacts (Yu et al., 2009; Jing et al., 2011). These
changes in expression are governed by a set of transcription fac-
tors such as Twist1 and Snail, both of which are regulators of EMT
during gastrulation and palate development (Yu et al., 2008, 2009;
Qin et al., 2012). Thus, EMT involves both a reorganization of
the cytoskeleton and a major shift in gene expression. So, how do
ephrins contribute to these events?
Part of the answer is found in the EMT that is required for
metastasis of epithelia-derived tumors (Thiery, 2002). In cer-
tain settings, repulsion between Ephs and ephrins serves to keep
potentially cancerous cells within their niche, such as in the colon,
where ephrins keep intestinal crypt stem cells from migrating
to the luminal ends of villi to form tumors (Holmberg et al.,
2006; Genander et al., 2009). In instances such as these, Ephs
FIGURE 2 | Two proposed models of ephrin-B reverse signaling in
palatal EMT based on current evidence. Pathway 1 places ephrin
signaling downstream of Tgfß3 signaling such that Tgfß3 stimulates
expression of EphBs and/or ephrin-Bs, leading to activation of PI3K
signaling. In pathway 2, Tgfß3 and ephrin-B signaling act in parallel to
stimulate PI3K together. Pathways 1 and 2 are not mutually exclusive.
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appear to function as tumor suppressors. In many other cases;
however, ephrins are upregulated in cancers, and their expression
is associated with increased EMT and metastasis of malignancies.
As mentioned above, the study by Astin et al. demonstrated that
ephrin reverse signaling enables the loss of contact inhibition seen
in prostate cancer cells and promotes their migration past nor-
mal fibroblasts (Astin et al., 2010). Our novel finding of PI3K
involvement in ephrin reverse signaling provides a connection
to this migration mechanism. PI3K signals to Akt, which acti-
vates the mTor complex, leading to migration of cancer cells. This
pathway is frequently activated in malignancies, and inhibition
of the mTor complex proteins Raptor and Rictor retards cancer
cell invasiveness and suppresses the EMT required for metastasis
(Gulhati et al., 2011). This mechanism may control the EMT and
migration of epithelial cells during palatal fusion (Figure 2).
The PI3K/Akt/mTor system also connects to transcriptional
activation associated with cancer EMT. The mTor kinase phos-
phorylates the signal transducer and activator of transcription 3
(Stat3) on Ser727, and thereby activates a transcriptional program
of growth and invasiveness (Yokogami et al., 2000; Zhou et al.,
2007). Stat3 activation is frequently associated with carcinoma
invasiveness and poor prognosis (Yue et al., 2012). Active Stat3
upregulates Twist1 and Snail, which in turn suppress E-cadherin
expression (Yamashita et al., 2004; Qin et al., 2012). Svoboda
et al. demonstrated that Twist1 regulates palatal fusion (Yu et al.,
2008). Thus, PI3K potentially connects ephrin-B reverse signal-
ing to an EMT-associated gene expression program in palate.
Phosporylated ephrin-B1 was also reported to bind directly to
Stat3 in embryos and tumor cells, suggesting that direct recruit-
ment of this transcription factor to the cytoplasmic domain
of ephrin-Bs contributes to its activation (Bong et al., 2007).
In addition to being a transcriptional activator, the ephrin-B1
cytodomain has been shown to bind the transcriptional repres-
sor Groucho/TLE (Kamata et al., 2011). Though the significance
of this binding to EMT is unknown, Groucho has been reported
to repress transcription downstream of Tgfß signaling, thus pro-
viding another potential cross-interaction with the Tgfß3 system
in palate (Hasson and Paroush, 2006).
CONCLUSION
The study of ephrins in palate development is still in its infancy.
We now know that ephrin forward signaling is necessary for early
palatal shelf growth, and that ephrin reverse signaling is required
for fusion of those shelves. Important questions remain, such
as: (1) which Ephs and ephrins control fusion, (2) what are the
specific downstream effectors of Ephs and ephrins in palatal mes-
enchyme and epithelium, (3) how do Tgfß3 and ephrin signaling
pathways intersect, and (4) what elements of the transcriptional
program in palatal EMT are controlled by ephrin signaling?
The large collection of molecular and genetic tools available for
studying ephrins in development makes it certain that efforts
to answer these questions will accelerate in the coming years,
and this will benefit both the fields of craniofacial biology and
cancer.
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